[Recording available] Immuno-oncology research workshop | Day 1
2023-01-31 | 07:30 AM - 10:30 AM (GMT+01:00) Paris
Information
HYBRID WORKSHOP ON IMMUNO-ONCOLOGY
< Day 1 >
Program of the first day
15.30-15.45 Opening
Moderator: Prof. Didier MARTY-DESSUS, Counsellor for Science and Technology,
Embassy of France
- Mr Tetsuya ITANI, Director - Office of Global Health Cooperation, International
- Affairs Division, Ministry of Health, Labour and Welfare
- Dr. Hitoshi NAKAGAMA, President, National Cancer Center of Japan
- Prof. Norbert IFRAH, President of the French National Cancer Institute
- Mr Thierry BRETON, General Director of the French National Cancer Institute
15.45-16.20 Session 1
Franco-Japanese Immuno-Oncology webinar series - wrap up and key messages
Chair: Dr Hiroyuki Mano
- Dr Hiroyoshi Nishikawa, National Cancer Center
16.20-17.05 Session 2
Genomics and metabolomics of the immune microenvironment
Chair: Dr Hiroyuki MANO
- Overcoming Cancer Immunotherapy Resistance Caused by Tumor-Derived Metabolites, Dr. Shogo KUMAGAI, National Cancer Center
- Raison d'être of gut microbiome: Immune regulation and beyond, Prof. Koji HASE, Keio University
17.05-17.20 Break
17.20-18.30 Session 3
Heterogeneity, clonal evolution and immune response
Chair: Dr. Hiroyoshi NISHIKAWA
- Immune cells with somatic mutations function as a niche for cancer cells - clonal hematopoiesis and cancers, Prof. Mamiko SAKATA, University of Tsukuba
- Clonal evolution in normal lung tissue leading to lung cancer development, Dr. Kenichi YOSHIDA, National Cancer Center
- Tertiary lymphoid structures in cancer patients: a biomarker and a target for next generation of immunotherapy, Dr. Marie-Caroline DIEU-NOSJEAN, Centre d’Immunologie et des Maladies Infectieuses (CIMI)- Paris (online)
18.30-19.00 Session 4
Development of immune-based targeted therapies
Chair: Dr. Hiroyoshi NISHIKAWA
- Restriction of PD-1 function for optimal T cell responses, Prof. Taku OKAZAKI, University of Tokyo